Sign inJoin waitlistJoin the waitlist

CC

Catherine Coombs

Associate Program Director · University of California

Credentials: · · · · · · ·

History

MSKCC
2021–2022
Hematology and Medical Oncology
2018–2021
Pathology-Anatomic and Clinical
Duke Department of Medicine
2014–2018
Internal Medicine
Duke University Hospital
2011–2014
University of Cincinnati College of Medicine
2006–2010

Research

Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
Cell stem cell · 2017 · First of 15 authors · 725 citations
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
Nature Genetics · 2020 · 651 citations
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
The Lancet · 2021 · 391 citations

Lindsey Roeker
21 papers · 8 as a fellow
Nicole Lamanna
16 papers
Anthony Mato
15 papers
Joanna Rhodes
15 papers · 3 as a fellow
Mazyar Shadman
14 papers
Alan Skarbnik
13 papers
Chaitra Ujjani
13 papers
Jennifer Brown
13 papers
Joshua Zeidner
13 papers
Paul Barr
13 papers
Jennifer Woyach
11 papers
MF
Matthew Foster
11 papers

Clinical trials

Epcoritamab as Consolidation Therapy for High-Risk Pts w/CLL on BTKI
Principal investigator · Not yet recruiting · Phase 2
University of California, Irvine
2026–2032
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Site PI · Recruiting · Phase 1
Carna Biosciences, Inc.
2023–2027
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2021–2028